Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Cash from Financing Activities (2021 - 2025)

Senti Biosciences has reported Cash from Financing Activities over the past 5 years, most recently at $11.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 78.48% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.8 million, down 78.11%, while the annual FY2025 figure was $11.8 million, 78.11% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $11.0 million at Senti Biosciences, up from $124000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $232.0 million in Q2 2021 and troughed at -$485000.0 in Q3 2022.
  • A 5-year average of $51.8 million and a median of $876000.0 in 2022 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 100.21% in 2022 and later surged 10708.7% in 2024.
  • Year by year, Cash from Financing Activities stood at $232.0 million in 2021, then plummeted by 99.62% to $876000.0 in 2022, then crashed by 36.53% to $556000.0 in 2023, then soared by 9124.82% to $51.3 million in 2024, then tumbled by 78.48% to $11.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for SNTI at $11.0 million in Q4 2025, $124000.0 in Q3 2025, and $1.0 million in Q2 2025.